Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2007

01-01-2007 | EPIDEMIOLOGY

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review

Authors: Valérie Bonadona, Sophie Dussart-Moser, Nicolas Voirin, Olga M Sinilnikova, Hervé Mignotte, Patrice Mathevet, Alain Brémond, Isabelle Treilleux, Alain Martin, Pascale Romestaing, Daniel Raudrant, René-Charles Rudigoz, Gilbert M. Lenoir, Christine Lasset

Published in: Breast Cancer Research and Treatment | Issue 2/2007

Login to get access
Metadata
Title
Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review
Authors
Valérie Bonadona
Sophie Dussart-Moser
Nicolas Voirin
Olga M Sinilnikova
Hervé Mignotte
Patrice Mathevet
Alain Brémond
Isabelle Treilleux
Alain Martin
Pascale Romestaing
Daniel Raudrant
René-Charles Rudigoz
Gilbert M. Lenoir
Christine Lasset
Publication date
01-01-2007
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9288-7

Other articles of this Issue 2/2007

Breast Cancer Research and Treatment 2/2007 Go to the issue

Preclinical study

The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells

Epidemiology

Influence of Timing of Initiation of Adjuvant Chemotherapy Over Survival in Breast Cancer: A Negative Outcome Study by the Spanish Breast Cancer Research Group (GEICAM)

Preclinical Study

Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type Lectin

Preclinical Study

MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor

Preclinical Study

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys

Preclinical Study

Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits